CCM
Camber Capital Management’s Gilead Sciences GILD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-2,500,000
| Closed | -$149M | – | 41 |
|
|
2022
Q1 | $149M | Buy |
2,500,000
+250,000
| +11% | +$14.9M | 5.38% | 5 |
|
|
2021
Q4 | $163M | Buy |
2,250,000
+1,150,000
| +105% | +$83.5M | 5.61% | 6 |
|
|
2021
Q3 | $76.8M | Sell |
1,100,000
-300,000
| -21% | -$21M | 2.37% | 18 |
|
|
2021
Q2 | $96.4M | Buy |
1,400,000
+400,000
| +40% | +$27.5M | 3.25% | 13 |
|
|
2021
Q1 | $64.6M | Buy |
+1,000,000
| New | +$64.6M | 2.22% | 15 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 34 |
|
|
2020
Q1 | – | Sell |
-1,500,000
| Closed | -$97.5M | – | 31 |
|
|
2019
Q4 | $97.5M | Buy |
+1,500,000
| New | +$97.5M | 4.96% | 4 |
|
|
2019
Q3 | – | Sell |
-1,000,000
| Closed | -$67.6M | – | 33 |
|
|
2019
Q2 | $67.6M | Buy |
+1,000,000
| New | +$67.6M | 3.15% | 11 |
|
|
2017
Q4 | – | Sell |
-500,000
| Closed | -$40.5M | – | 33 |
|
|
2017
Q3 | $40.5M | Sell |
500,000
-1,500,000
| -75% | -$122M | 2.57% | 16 |
|
|
2017
Q2 | $142M | Buy |
2,000,000
+100,000
| +5% | +$7.08M | 6.89% | 3 |
|
|
2017
Q1 | $129M | Buy |
1,900,000
+400,000
| +27% | +$27.2M | 5.23% | 3 |
|
|
2016
Q4 | $107M | Buy |
1,500,000
+300,000
| +25% | +$21.5M | 5.59% | 4 |
|
|
2016
Q3 | $94.9M | Buy |
1,200,000
+450,000
| +60% | +$35.6M | 4.17% | 4 |
|
|
2016
Q2 | $62.6M | Buy |
+750,000
| New | +$62.6M | 3.02% | 10 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 48 |
|